Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro

• Andreas Matthäus Bader,

  Affiliations Berlin-Brandenburg Center for Regenerative Therapies, Charité—Universitätsmedizin Berlin, Berlin, Germany, Deutsches Herzzentrum Berlin, Berlin, Germany

  ⨯
• Kristin Klose,

  Affiliation Berlin-Brandenburg Center for Regenerative Therapies, Charité—Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Karen Bieback,

  Affiliation Institute of Transfusion Medicine and Immunology, Ruprecht-Karls University of Heidelberg, Mannheim, Germany

  ⨯
• Dirk Korinth,

  Affiliation Labor Berlin GmbH, Berlin, Germany

  ⨯
• Maria Schneider,

  Affiliation Berlin-Brandenburg Center for Regenerative Therapies, Charité—Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Martina Seifert,

  Affiliation Berlin-Brandenburg Center for Regenerative Therapies, Charité—Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Yeong-Hoon Choi,

  Affiliation Heart Center, University of Cologne, Cologne, Germany

  ⨯
• Andreas Kurtz,

  Affiliation Berlin-Brandenburg Center for Regenerative Therapies, Charité—Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Volkmar Falk,

  Affiliation Deutsches Herzzentrum Berlin, Berlin, Germany

  ⨯
• Christof Stamm

  * E-mail: stamm@dhzb.de

  Affiliations Berlin-Brandenburg Center for Regenerative Therapies, Charité—Universitätsmedizin Berlin, Berlin, Germany, Deutsches Herzzentrum Berlin, Berlin, Germany

  ⨯